{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:34:38Z","timestamp":1763642078376},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejphar.2016.06.012","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T14:43:10Z","timestamp":1465656190000},"page":"1-11","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injury"],"prefix":"10.1016","volume":"788","author":[{"given":"Chang Z.","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujatha","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L.","family":"Nikkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek C.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Leys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Widomski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Salte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent","family":"Putman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve P.","family":"McGaraughty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejphar.2016.06.012_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12350-011-9508-3","article-title":"A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease","volume":"19","author":"Ananthasubramaniam","year":"2012","journal-title":"J. Nucl. Cardiol."},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.012_bib2","doi-asserted-by":"crossref","first-page":"F828","DOI":"10.1152\/ajprenal.00310.2005","article-title":"Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy","volume":"290","author":"Awad","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2016.06.012_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1681\/ASN.2007030276","article-title":"Activation of adenosine 2A receptors preserves structure and function of podocytes","volume":"19","author":"Awad","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2 Pt 2","key":"10.1016\/j.ejphar.2016.06.012_bib4","first-page":"F241","article-title":"Anti-GBM antibody-induced proteinuria in isolated perfused rat kidney","volume":"249","author":"Couser","year":"1985","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.ejphar.2016.06.012_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/41.3.7679127","article-title":"Conventional and confocal fluorescence microscopy of collagen fibers in the heart","volume":"41","author":"Dolber","year":"1993","journal-title":"J. Histochem. Cytochem."},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2016.06.012_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2013.05.024","article-title":"ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy","volume":"93","author":"Elsherbiny","year":"2013","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.012_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ki.2011.167","article-title":"Adenosine A(2A) agonists as therapy for glomerulonephritis","volume":"80","author":"Ferenbach","year":"2011","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.012_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ki.2011.101","article-title":"Adenosine A(2A) receptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation","volume":"80","author":"Garcia","year":"2011","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.ejphar.2016.06.012_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1096\/fj.07-8430com","article-title":"Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis","volume":"22","author":"Garcia","year":"2008","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.ejphar.2016.06.012_bib10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/0091270007301620","article-title":"Regadenoson pharmacokinetics and tolerability in subjects with impaired renal function","volume":"47","author":"Gordi","year":"2007","journal-title":"J. Clin. Pharm."},{"issue":"3","key":"10.1016\/j.ejphar.2016.06.012_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1189\/jlb.0607359","article-title":"A2A receptors in inflammation and injury: lessons learned from transgenic animals","volume":"83","author":"Hasko","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.ejphar.2016.06.012_bib12","doi-asserted-by":"crossref","first-page":"e40584","DOI":"10.1371\/journal.pone.0040584","article-title":"The A2b adenosine receptor modulates glucose homeostasis and obesity","volume":"7","author":"Johnston-Cox","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejphar.2016.06.012_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.111.057596","article-title":"A2b adenosine receptor regulates hyperlipidemia and atherosclerosis","volume":"125","author":"Koupenova","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ejphar.2016.06.012_bib14","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1172\/JCI63170","article-title":"Dendritic cells tolerized with adenosine A(2)AR agonist attenuate acute kidney injury","volume":"122","author":"Li","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.ejphar.2016.06.012_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1681\/ASN.2007040486","article-title":"The role of osteopontin in the development of albuminuria","volume":"19","author":"Lorenzen","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.ejphar.2016.06.012_bib16","first-page":"31","article-title":"The renal adenosine system: structure, function, and regulation","volume":"13","author":"McCoy","year":"1993","journal-title":"Semin. Nephrol."},{"issue":"3","key":"10.1016\/j.ejphar.2016.06.012_bib17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000319238","article-title":"Osteopontin overproduction is associated with progression of glomerular fibrosis in a rat model of anti-glomerular basement membrane glomerulonephritis","volume":"32","author":"Merszei","year":"2010","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.ejphar.2016.06.012_bib18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/excr.1997.3739","article-title":"Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines","volume":"236","author":"Mundel","year":"1997","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.ejphar.2016.06.012_bib19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000189049","article-title":"Cytotoxicity of sera from rats with puromycin aminonucleoside nephrosis","volume":"73","author":"Natori","year":"1996","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.ejphar.2016.06.012_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2613.2000.00163.x","article-title":"Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation","volume":"81","author":"O'Regan","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.ejphar.2016.06.012_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0002-9440(10)62977-X","article-title":"Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat","volume":"167","author":"Pawelczyk","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.ejphar.2016.06.012_bib22","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2016.06.012_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2014.05.004","article-title":"Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms","volume":"85","author":"Pye","year":"2014","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.012_bib24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2174\/1389450111314040010","article-title":"Targeting adenosine signaling to treatment of diabetic nephropathy","volume":"14","author":"Quezada","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.012_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ki.2014.244","article-title":"The role of adenosine receptors A2A and A2B signaling in renal fibrosis","volume":"86","author":"Roberts","year":"2014","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.ejphar.2016.06.012_bib26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"Saleem","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.ejphar.2016.06.012_bib27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diabetes.53.3.784","article-title":"Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease","volume":"53","author":"Susztak","year":"2004","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ejphar.2016.06.012_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jjcc.2012.07.016","article-title":"Estimated glomerular filtration rate and proteinuria are associated with persistent form of atrial fibrillation: analysis in Japanese patients","volume":"61","author":"Suzuki","year":"2013","journal-title":"J. Cardiol."},{"issue":"7","key":"10.1016\/j.ejphar.2016.06.012_bib29","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/ATVBAHA.109.188839","article-title":"Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis","volume":"29","author":"Wang","year":"2009","journal-title":"Arter. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.012_bib30","doi-asserted-by":"crossref","first-page":"e60173","DOI":"10.1371\/journal.pone.0060173","article-title":"Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy","volume":"8","author":"Xiao","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejphar.2016.06.012_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.acthis.2012.09.002","article-title":"The effects of adenosine A2A receptor knockout on renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction","volume":"115","author":"Xiao","year":"2013","journal-title":"Acta Histochem."},{"issue":"18","key":"10.1016\/j.ejphar.2016.06.012_bib32","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/S0960-894X(03)00642-5","article-title":"Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivity","volume":"13","author":"Zheng","year":"2003","journal-title":"Bioorg. Med Chem. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916303715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916303715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T15:44:34Z","timestamp":1656690274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916303715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":32,"alternative-id":["S0014299916303715"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.012","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injury","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}